• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用高分辨率和低分辨率垂直 SDS-琼脂糖凝胶电泳和 Cy5 标记抗体高灵敏度荧光检测同时分析血管性血友病因子多聚体。

Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection.

机构信息

Medical University Innsbruck, Anichstr 35, A-6020 Innsbruck, Austria.

出版信息

Am J Clin Pathol. 2010 Feb;133(2):322-30. doi: 10.1309/AJCPZSBTD2BWOMVL.

DOI:10.1309/AJCPZSBTD2BWOMVL
PMID:20093243
Abstract

Analysis of von Willebrand factor (vWF) multimers allows classification of the subtypes of von Willebrand disease (vWD) in human serum and platelet lysates. A novel method for multimer analysis of vWF by 2-chamber, vertical (sodium dodecyl sulfate), agarose gel electrophoresis, designed for comparing discontinuous high- and low-resolving gels for plasma and platelets, followed by Western blotting and high-sensitivity fluorescence detection (HSFD) of cyanine (Cy)5-labeled vWF multimers is presented. HSFD shows that this method has high discriminatory power for visualization and densitometric analysis of platelets and plasma vWF multimers in various types of vWD and allows rapid classification of vWD types, to separate types 2A and 2B. The described procedures of vWF multimer analysis with high-sensitivity Cy5 fluorescence detection and direct comparison of high- and low-resolving gels for screening and detection of the complete range of high- and low-molecular vWF multimers is efficient and useful for screening, detecting, and classifying vWD subtypes and makes this method diagnostically and clinically relevant.

摘要

分析血管性血友病因子 (vWF) 多聚体可将人血清和血小板裂解物中的血管性血友病 (vWD) 亚型进行分类。本研究设计了一种用于 2 室、垂直 (十二烷基硫酸钠)、琼脂糖凝胶电泳分析 vWF 多聚体的新方法,该方法用于比较用于血浆和血小板的不连续高分辨和低分辨凝胶,并通过 Cy5 标记的 vWF 多聚体的 Western 印迹和高灵敏度荧光检测 (HSFD) 进行分析。HSFD 表明,该方法对于可视化和密度计分析各种类型 vWD 中的血小板和血浆 vWF 多聚体具有高分辨力,并允许快速分类 vWD 类型,以区分 2A 和 2B 型。该文描述的用高灵敏度 Cy5 荧光检测进行 vWF 多聚体分析的程序,并直接比较高分辨和低分辨凝胶,用于筛选和检测完整范围的高分子量和低分子量 vWF 多聚体,是一种高效且有用的方法,可用于筛选、检测和分类 vWD 亚型,并使该方法具有诊断和临床意义。

相似文献

1
Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection.采用高分辨率和低分辨率垂直 SDS-琼脂糖凝胶电泳和 Cy5 标记抗体高灵敏度荧光检测同时分析血管性血友病因子多聚体。
Am J Clin Pathol. 2010 Feb;133(2):322-30. doi: 10.1309/AJCPZSBTD2BWOMVL.
2
Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex.使用抗生物素蛋白-生物素过氧化物酶复合物通过免疫酶染色法观察血管性血友病因子多聚体。
Thromb Haemost. 1986 Apr 30;55(2):263-7.
3
Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.遗传性2A型、2B型、2C型、2D型、2E型、2M型、2N型和2U型(无法分类)血管性血友病的分类与特征描述
Clin Appl Thromb Hemost. 2006 Oct;12(4):397-420. doi: 10.1177/1076029606293422.
4
Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry.通过光密度测定法对血管性血友病因子多聚体模式进行定量分析并促进比较。
Am J Clin Pathol. 2001 Oct;116(4):567-74. doi: 10.1309/75CQ-V7UX-4QX8-WXE7.
5
Native multimer analysis of plasma and platelet von Willebrand factor compared to denaturing separation: implication for the interpretation of satellite bands.比较天然多聚体分析和变性分离的血浆和血小板血管性血友病因子:对卫星带解释的影响。
Electrophoresis. 2011 Jun;32(13):1684-91. doi: 10.1002/elps.201000662. Epub 2011 Jun 6.
6
Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes.在琼脂糖凝胶和硝酸纤维素膜上对血管性血友病因子多聚体进行发光检测。
Thromb Haemost. 1990 Apr 12;63(2):312-5.
7
Improved characterization of plasma von Willebrand factor heterogeneity when using 2.5% agarose gel electrophoresis.使用2.5%琼脂糖凝胶电泳时,血浆血管性血友病因子异质性的特征得到改善。
Thromb Haemost. 1986 Feb 28;55(1):61-4.
8
[Diagnostic strategies for detection of the von Willebrand syndrome].[血管性血友病综合征检测的诊断策略]
Beitr Infusionsther. 1992;30:268-71.
9
A comparative study of three methods for the visualization of von Willebrand factor (vWF) multimers.三种可视化血管性血友病因子(vWF)多聚体方法的比较研究。
Thromb Haemost. 1990 Dec 28;64(4):569-75.
10
Visualization of von Willebrand factor multimers by enzyme-conjugated secondary antibodies.通过酶偶联二抗可视化血管性血友病因子多聚体
Thromb Haemost. 1986 Apr 30;55(2):276-8.

引用本文的文献

1
Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug-induced thromboembolism.血栓反应蛋白-1 是 cereblon 的内源性底物,负责免疫调节药物引起的血栓栓塞。
Blood Adv. 2024 Feb 13;8(3):785-796. doi: 10.1182/bloodadvances.2023010080.
2
von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells.血管性血友病因子前肽变异导致患者来源的内皮细胞集落形成细胞储存和内质网滞留受损。
J Thromb Haemost. 2022 Jul;20(7):1599-1609. doi: 10.1111/jth.15740. Epub 2022 May 3.
3
Characterization of Von Willebrand Factor Multimer Structure in Patients With Severe Aortic Stenosis.
严重主动脉瓣狭窄患者血管性血友病因子多聚体结构的特征分析
Clin Appl Thromb Hemost. 2018 Apr;24(3):496-501. doi: 10.1177/1076029617744321. Epub 2017 Dec 4.
4
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.重组ADAMTS-13:先天性血栓性血小板减少性紫癜的首次人体药代动力学和安全性研究
Blood. 2017 Nov 9;130(19):2055-2063. doi: 10.1182/blood-2017-06-788026. Epub 2017 Sep 14.
5
Flow-induced elongation of von Willebrand factor precedes tension-dependent activation.血流诱导的血管性血友病因子伸长先于张力依赖性激活。
Nat Commun. 2017 Aug 23;8(1):324. doi: 10.1038/s41467-017-00230-2.
6
The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.血管性血友病的诊断与管理:英国血友病中心医生组织指南,经英国血液学标准委员会批准。
Br J Haematol. 2014 Nov;167(4):453-65. doi: 10.1111/bjh.13064. Epub 2014 Aug 12.
7
A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice.包含D'D3结构域的血管性血友病因子片段足以在小鼠体内稳定凝血因子VIII。
Blood. 2014 Jul 17;124(3):445-52. doi: 10.1182/blood-2013-11-540534. Epub 2014 May 21.